The case study presents an overview of clinical use studies that MediPurpose’
The results consistently indicated that Austrian users found babyLance to be satisfactory for:
• Safety: babyLance’s safety features protected the user from accidental needlestick injury
• Training: babyLance’s instructions for use (IFU) and intuitive design fostered ease of use
• Ergonomics: The device and its packaging were comfortable and easy to use
• Trigger: The new “pull-back”
• Usage: Compared to the user’s current device, babyLance was easy to use, and its precise incision provided an adequate volume of blood for collection
Notably, the studies returned a perfect score for safety and a 94-percent score for ease-of-use, ergonomics and performance tests.
“We were delighted with the very positive responses from babyLance’s clinical use tests in Austria,” said MediPurpose founder and CEO Patrick Yi, who led the heelstick design team. “Along with validating the numerous improvements we made to the new babyLance, it was affirming to learn that Austrian neonatal nurses were enjoying the same levels of experience with the device as nurses in the United States.”
According to the case study, heelstick devices have not yet become a prominent device for infant heelstick incision procedures in Europe, which can be performed several times a day to collect blood samples. Rather than heelsticks, European caregivers typically use fingerstick devices (such as the SurgiLance™ safety lancet).
“It is our hope that European nurses will continue to discover the wealth of advantages with using a safety heelstick instead of a fingerstick,”
About babyLance Safety Heelsticks
The new babyLance safety heelstick is a fully redesigned iteration of MediPurpose’
It is also the only heelstick to receive U.S. Food and Drug Administration (FDA) 510(k) clearance with sharps prevention indications, which permits the company to market babyLance as a safety medical device in the United States of America.
Used by neonatal caregivers to collect blood samples from infants, the new babyLance features an ergonomic design to provide a secure and stable grip.
Combined with a redesigned trigger mechanism, the heelstick device is easy to activate, helping to deliver a consistent incision without damaging the baby’s tender nerve fibers.
babyLance heelstick devices are available in two models:
• The babyLance BLP (http://www.medipurpose.com/
• The babyLance BLN (http://www.medipurpose.com/
To download free case studies and white papers, please visit www.medipurpose.com/
For more information about babyLance—including pricing and no-cost product sample requests—please visit www.medipurpose.com/
Founded in 1999, MediPurpose is an innovative medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance™ safety heelstick (http://medipurpose.com/
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors (http://www.medipurpose.com/
For more information about MediPurpose’